Medication info

Hana Atenolol Tablets

Prescription medicationApproval withdrawn
Ingredient · strength
Atenolol›Strength being verified
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 199501905 · Notified 1995.03.30

This product's status changed to Approval withdrawn on 2023.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and angina
Who uses it
Adults
Adult dosage
1. Hypertension: The initial adult dose is atenolol 50㎎ once daily, administered orally alone or in combination with a diuretic (thiazide). If an effect is not observed within 1-2 weeks, increase the dose to 100㎎ once daily. Do not exceed 100㎎ per day. 2. Angina: Administer 100㎎ of this medicine per day in 1-2 divided doses. Do not exceed 100㎎ per day. 3. Patients with renal impairment Creatinine clearance (㎖/min/1.73㎡) Dose 15-35 50㎎ per day <15 25㎎ per day or 50㎎ every 2 days The dose may be adjusted appropriately according to age and symptoms.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and angina

  • Hypertension
  • angina
View approved original text

This medication is used for hypertension and angina.

Dosage and Administration

Adult dosage

1. Hypertension: The initial adult dose is atenolol 50㎎ once daily, administered orally alone or in combination with a diuretic (thiazide). If an effect is not observed within 1-2 weeks, increase the dose to 100㎎ once daily. Do not exceed 100㎎ per day. 2. Angina: Administer 100㎎ of this medicine per day in 1-2 divided doses. Do not exceed 100㎎ per day. 3. Patients with renal impairment Creatinine clearance (㎖/min/1.73㎡) Dose 15-35 50㎎ per day <15 25㎎ per day or 50㎎ every 2 days The dose may be adjusted appropriately according to age and symptoms.

Precautions

This medication should not be administered to patients with allergic reactions to the main ingredient or additives. It is contraindicated in patients with severe bronchial asthma or chronic obstructive pulmonary disease. Patients experiencing diabetic ketoacidosis or metabolic acidosis should also avoid this medication. It should not be administered to patients with bradycardia or cardiac conduction disorders, cardiogenic shock patients, or those with severe heart failure due to pulmonary hypertension. Additionally, patients with severe hypotension or peripheral circulatory disorders, as well as those with syndrome of inappropriate antidiuretic hormone secretion, should not use this medication. Patients at risk for developing thyrotoxicosis due to thyroid dysfunction, or those with untreated pheochromocytoma should also avoid this medication. This medication contains lactose, thus should not be taken by patients with lactose intolerance or certain genetic lactose metabolism disorders. Patients at risk of bronchial asthma or bronchospasm should use this medication with caution and may need to use a bronchodilator as necessary. Patients with congestive heart failure should observe their condition carefully when taking this medication. Patients with diabetes or hypoglycemia should take this medication carefully while closely monitoring blood glucose changes. Patients with severe liver or kidney dysfunction also require caution. Elderly patients should start at a lower dose and closely monitor their condition. Long-term use of this medication requires regular monitoring of heart function, blood pressure, and electrocardiograms, and doses should be reduced or stopped if abnormalities are found. Abrupt discontinuation of this medication can worsen symptoms of heart disease, thus it should be tapered off according to a doctor's instructions. Patients scheduled for surgery should stop taking this medication 24 hours before the procedure and caution should be observed during anesthesia as well. Dizziness can occur during the use of this medication, so driving or operating dangerous machinery should be avoided. Moreover, this medication may interact with several other drugs, so inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or breastfeeding should use this medication cautiously as it may affect the fetus or newborn, and it is advisable to discontinue breastfeeding if possible. The safety of this medication in children has not been established, thus it should be used cautiously in pediatric patients. In case of overdose, severe bradycardia, hypotension, and bronchospasm may occur, necessitating immediate medical attention.

Side effects

  • Rash
  • itching
  • vascular edema
  • hives
  • decreased tear secretion
  • blurred vision
  • visual impairment
  • dry eyes
  • bradycardia
  • cold extremities
Show 88 more
  • palpitations
  • cardiomegaly
  • chest tightness
  • hypotension
  • cold sensation in limbs
  • atrioventricular block
  • sinoatrial block
  • orthostatic hypotension
  • leg pain
  • heart failure
  • facilitation of heart block
  • intermittent claudication
  • Raynaud's phenomenon
  • confusion
  • mood changes
  • nightmares
  • psychiatric disorders
  • hallucinations
  • sleep disorders
  • heaviness of the head
  • dizziness
  • orthostatic dysregulation
  • insomnia
  • drowsiness
  • congestive state
  • ringing
  • tinnitus
  • ear pain
  • fatigue
  • weakness
  • lethargy
  • headache
  • sensory disturbance
  • altered consciousness
  • gastrointestinal disturbances
  • thirst
  • nausea
  • vomiting
  • decreased appetite
  • abdominal discomfort
  • diarrhea
  • loose stools
  • constipation
  • abdominal pain
  • wheezing
  • shortness of breath
  • bronchial spasm
  • bronchial contraction
  • elevated AST
  • elevated ALT
  • intrahepatic cholestasis
  • elevated BUN
  • elevated creatinine
  • papules
  • psoriasis
  • psoriatic papules
  • alopecia
  • purpura
  • thrombocytopenia
  • erectile dysfunction
  • numbness
  • edema
  • peripheral edema
  • sweating
  • cold
  • increased urination
  • elevated transaminase levels
  • hyperlipidemia
  • hyperglycemia
  • hyperuricemia
  • elevated CPK
  • agranulocytosis
  • nonthrombocytopenic purpura
  • thrombocytopenic purpura
  • tonsillitis
  • laryngospasm
  • respiratory difficulties
  • liver disease
  • visual impairment
  • disorientation
  • short-term memory loss
  • emotional instability
  • neuropsychiatric disorders
  • mesenteric artery thrombosis
  • ischemic colitis
  • reversible alopecia
  • Peyronie's disease
  • erythematous rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, away from direct sunlight, and preferably at room temperature. Room temperature generally refers to temperatures between 15 degrees and 25 degrees Celsius, and extremes of heat or cold should be avoided. Storing it this way will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.